ES2175989T3 - Derivado de testosterona. - Google Patents

Derivado de testosterona.

Info

Publication number
ES2175989T3
ES2175989T3 ES99929208T ES99929208T ES2175989T3 ES 2175989 T3 ES2175989 T3 ES 2175989T3 ES 99929208 T ES99929208 T ES 99929208T ES 99929208 T ES99929208 T ES 99929208T ES 2175989 T3 ES2175989 T3 ES 2175989T3
Authority
ES
Spain
Prior art keywords
testosterone
derived
oxoundecyl
estr
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99929208T
Other languages
English (en)
Inventor
Dirk Leysen
Der Voort Hendrikus Adrian Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2175989T3 publication Critical patent/ES2175989T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

El compuesto (7,17)-7-metil-17-[(1-oxoundecil)oxi]estr-4-en-3-ona (undecanoato de MENT).
ES99929208T 1998-06-19 1999-06-14 Derivado de testosterona. Expired - Lifetime ES2175989T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98202052 1998-06-19

Publications (1)

Publication Number Publication Date
ES2175989T3 true ES2175989T3 (es) 2002-11-16

Family

ID=8233831

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99929208T Expired - Lifetime ES2175989T3 (es) 1998-06-19 1999-06-14 Derivado de testosterona.

Country Status (26)

Country Link
US (3) US6437158B1 (es)
EP (1) EP1087986B1 (es)
JP (1) JP2002518514A (es)
KR (1) KR100596649B1 (es)
CN (1) CN1172949C (es)
AT (1) ATE215961T1 (es)
AU (1) AU756739B2 (es)
BR (1) BR9911344A (es)
CA (1) CA2333985C (es)
CZ (1) CZ293319B6 (es)
DE (1) DE69901250T2 (es)
DK (1) DK1087986T3 (es)
ES (1) ES2175989T3 (es)
HK (1) HK1034263A1 (es)
HU (1) HUP0102274A3 (es)
ID (1) ID27260A (es)
IL (1) IL139689A (es)
NO (1) NO316518B1 (es)
NZ (1) NZ508299A (es)
PL (1) PL191285B1 (es)
PT (1) PT1087986E (es)
RU (1) RU2216546C2 (es)
SK (1) SK282796B6 (es)
TR (1) TR200003743T2 (es)
WO (1) WO1999067271A1 (es)
ZA (1) ZA200006813B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059920A2 (en) * 1999-04-06 2000-10-12 Akzo Nobel N.V. Orally active 7.alpha.-alkyl androgens
SK882003A3 (en) * 2000-07-28 2003-07-01 Akzo Nobel Nv 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use
JP3774888B2 (ja) * 2001-11-28 2006-05-17 日本化薬株式会社 ステロイド類化合物のｌｃ−ｍｓによる高感度検出法
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
TW200403065A (en) 2002-05-30 2004-03-01 Akzo Nobel Nv New etonogestrel esters
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP1879382B1 (en) 2006-07-10 2017-09-06 Samsung Electronics Co., Ltd. Multi-screen display apparatus and method for digital broadcast receiver
WO2008101030A1 (en) * 2007-02-13 2008-08-21 The Regents Of The University Of California Methods for amplifying steroid hormone effects
US20090017107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase libido
US20090018107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase muscle strength
US20100303937A1 (en) * 2009-06-01 2010-12-02 Michael Farber Novel composition to increase testosterone levels
CN102558267A (zh) * 2012-01-13 2012-07-11 宜城市共同药业有限公司 庚酸睾酮的制备方法
KR20150011346A (ko) * 2012-04-06 2015-01-30 안타레스 팔마, 인코퍼레이티드 테스토스테론 조성물의 바늘-보조식 젯 주입 투여 장치 및 방법
PT3659647T (pt) * 2013-02-11 2024-03-27 Antares Pharma Inc Dispositivo de injeção a jato auxiliado por agulha tendo força de gatilho reduzida

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation

Also Published As

Publication number Publication date
CZ293319B6 (cs) 2004-04-14
NO20006455D0 (no) 2000-12-18
ATE215961T1 (de) 2002-04-15
US6437158B1 (en) 2002-08-20
RU2216546C2 (ru) 2003-11-20
NO316518B1 (no) 2004-02-02
WO1999067271A1 (en) 1999-12-29
PL191285B1 (pl) 2006-04-28
TR200003743T2 (tr) 2001-07-23
US6989378B2 (en) 2006-01-24
NZ508299A (en) 2003-04-29
NO20006455L (no) 2000-12-18
EP1087986A1 (en) 2001-04-04
IL139689A (en) 2004-09-27
CN1172949C (zh) 2004-10-27
ZA200006813B (en) 2002-02-21
DE69901250D1 (de) 2002-05-16
CA2333985C (en) 2007-04-10
EP1087986B1 (en) 2002-04-10
HUP0102274A3 (en) 2002-08-28
HK1034263A1 (en) 2001-10-19
PT1087986E (pt) 2002-08-30
ID27260A (id) 2001-03-22
SK19402000A3 (sk) 2001-07-10
CZ20004779A3 (en) 2001-06-13
AU756739B2 (en) 2003-01-23
CA2333985A1 (en) 1999-12-29
IL139689A0 (en) 2002-02-10
BR9911344A (pt) 2001-03-13
US20040033999A1 (en) 2004-02-19
DK1087986T3 (da) 2002-06-17
DE69901250T2 (de) 2002-10-17
JP2002518514A (ja) 2002-06-25
KR20010052850A (ko) 2001-06-25
PL344987A1 (en) 2001-11-19
HUP0102274A2 (hu) 2001-12-28
SK282796B6 (sk) 2002-12-03
AU4610199A (en) 2000-01-10
US20050153949A1 (en) 2005-07-14
CN1305488A (zh) 2001-07-25
KR100596649B1 (ko) 2006-07-06

Similar Documents

Publication Publication Date Title
ES2175989T3 (es) Derivado de testosterona.
ECSP034600A (es) Compuestos de lactama
WO1999064047A8 (en) Novel antiviral compounds
EG24814A (en) Novel compounds.
MXPA00007681A (es) Composiciones de epotilona.
EP1491542A3 (en) Intermediate compounds
IL160872A0 (en) Pyrimidinones as melanin concentrating hormone receptor 1
BR9713366B1 (pt) análogos de heptapeptìdeo oxitocina.
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
ZA200005369B (en) Calcilytic compounds.
EP1042352A4 (en) ANDROGENIC STEROID COMPOUNDS AND METHOD OF MANUFACTURE AND USE THEREOF
HK1019873A1 (en) Illudin analogs useful as antitumor agents.
GB2358395B (en) Tetrahydrofuran-adducted group 11 ß-diketonate complexes as source reagents for chemical vapor depostion
BR9906519A (pt) Conjunto de embreagem
AP2001002220A0 (en) Calcilytic compounds.
BR9912037B1 (pt) composições organometálicas.
MY116766A (en) Improved process for antiparasitic agent
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
AU2881399A (en) N1-modified glycopeptides
TR199901017A2 (xx) B�cek ilac� terkibi.
ZA992899B (en) Novel compound.
ZA9810063B (en) Process for the manufacture of an organic compound.
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
GB2348423B (en) Novel anhydrofructose antioxidant
AU8973398A (en) Organic compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1087986

Country of ref document: ES